Initially reported back on March 20th, T.J. Dillashaw (16-4) failed a drug test administered by USADA, and decided to voluntarily relinquish his UFC Bantamweight title. Claiming altruism at the time, it was clear then and it’s even clearer now, it was an admission of guilt. A clip that is now starting to gain a lot of traction again, is this clip from the pre-fight press conference for UFC 217, where ex-training partner turned two-time opponent Cody Garbrandt (11-3) accuses Dillashaw of PED use. Keep in mind, this is back in the fall of 2017:
Even crazier, there’s this:
Cody Garbrandt posted this on Twitter in April of 2018, specifically accusing Dillashaw of using EPO. pic.twitter.com/fiBXf3Z45z
— Aaron Bronsteter (@aaronbronsteter) April 9, 2019
I guess he isn’t exactly Nostradamus, as he did train with T.J. for a number of years, but it’s still pretty crazy to see a UFC fighter accuse another of something so specific and have it turn out to be true. As a result of the positive drug test, Dillashaw will be suspended for two years, dating back to his most recent fight in January.
Former UFC bantamweight champion T.J. Dillashaw has accepted a two-year suspension after testing positive for recombinant human erythropoietin (rHuEPO), the U.S. Anti-Doping Agency announced on Tuesday.
Dillashaw’s suspension is retroactive to the date of his in-competition test from Jan. 18, meaning he’ll be eligible to fight again on Jan. 18, 2021. The positive EPO test stems from his failed bid to capture the flyweight title from Henry Cejudo at UFC on ESPN+1.
Looks like we won’t be seeing Mr. Dillashaw in the cage for a while, and for good reason. After watching Dillashaw change his fighting style to mimic Dominick Cruz (22-2) and become champion a number of years ago, I can’t help but wonder if he would have been able to do that without the help of a Lance Armstrong cocktail.
Unfortunately we’ll never know.